Clinical trials treating focal segmental glomerulosclerosis should measure patient quality of life

Optimal therapy of patients with steroid-resistant primary focal segmental glomerulosclerosis (FSGS) remains controversial. This report describes the initial study design, baseline characteristics, and quality of life of patients enrolled in the FSGS Clinical Trial, a large multicenter randomized st...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Gipson, Debbie S., Trachtman, Howard, Kaskel, Frederick J., Radeva, Milena K., Gassman, Jennifer, Greene, Tom H., Moxey-Mims, Marva M., Hogg, Ronald J., Watkins, Sandra L., Fine, Richard N., Middleton, John P., Vehaskari, V. M., Hogan, Susan L., Vento, Suzzane, Flynn, Patti A., Powell, Leslie M., McMahan, June L., Siegel, Norman, Friedman, Aaron L.
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2010
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3306823/
https://ncbi.nlm.nih.gov/pubmed/21178977
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/ki.2010.485
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge